Journal of Allergy and Clinical Immunology-In Practice

Article	Citations
Table of Contents	163
Practice Notes from the AAAI	161
The impact of COVID-19 on a national sample of US adults with food allergy	131
Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use	123
Information for Readers	109
March 2023 Practice Notes	107
Managing Atopic Dermatitis in Patients With Skin of Color	99
CME exam: Practical Implementation of Genetics: New Concepts in Immunogenomics to Predict, Prevent, and Diagnose Drug Hypersensitivity	88
CME exam: Take a Leap of Faith: Implement Routine Genetic Testing in Your Office	87
Scratching the Itch: Managing Recurrent Pruritic Skin Conditions	86
CME Exam: Long-Term Respiratory Consequences of Early-Life Respiratory Viral Infections: A Pragmatic Approach to Fundamental Questions	82
Original Article Highlights From This Issue	80
COVID-19 Treatments: Then and Now	74
Keeping Our Eyes on the Prize: Personalized and Precision Medicine With Biologics for Chronic Rhinosinusitis With Nasal Polyps	73
Two-step nonsteroidal anti-inflammatory drug challenges during pregnancy: A case series	69
Ask Not What AI Can Do to Us, but What We Can Do with AI	69
Anaphylactic reaction to checkpoint inhibitors with confirmed hypersensitivity to polysorbate 80	68
Resolution of hypereosinophilic syndrome following resection of a schwannoma	66
Giant Papillary Conjunctivitis Caused by a Fibroepithelial Polyp of the Lower Eyelid	65
Adherence Challenges and Strategies in Specific Groups With Asthma: Adolescents, Pregnancy, and Older Adults	65
Could Corticosteroid/Antihistamine Combination Nasal Sprays Be Used as Anti-Inflammatory Reliever Therapy for Allergic Rhinitis?	64
Table of Contents	64
Once- or Twice-Daily Inhaler Therapy for Optimal Adherence: “No-Brainer” or Shared Decision?	64
Gene Therapy for Inborn Errors of Immunity	62
Respiratory Diseases Associated With Organic Dust Exposure	62

SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?	62
Information for Readers	60
Generational Consequences From Historical Redlining: Longitudinal Impacts on Air Pollution and Asthma Health Outcomes	60
Spirometric Changes in Bronchodilation Tests as Predictors of Asthma Diagnosis and Treatment Response in Patients with FEV1 ≥ 80% Predicted	57
Managing CPAP Rhinitis	57
Cumulative Dose Effects of H1 Antihistamine Use on the Risk of Dementia in Patients With Allergic Rhinitis	57
Macular Amyloidosis in an Atopic Patient After Aeroallergen Immunotherapy	57
Quality and Safety: Learning from the Past and (Re)Imagining the Future	55
Triggers for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy	55
Feeding difficulties in children with food protein–induced enterocolitis syndrome	54
Table of Contents	53
Effects of Pregnancy-Onset Asthma on Perinatal Outcomes: A Retrospective Cohort Study	53
Weight Loss Interventions for Adults With Obesity-Related Asthma	53
Development of Food Allergy Data Dictionary: Toward a Food Allergy Data Commons	51
Persistent nivolumab-induced urticaria with vibratory and delayed-pressure angioedema	51
Measuring Cough Severity: Time to Replace VAS With Patient Global Impression Scale?	51
Impact of Ongoing Treatment With Inhaled Corticosteroids During Specific Inhalation Challenges for Diagnosing Occupational Asthma	50
Facilitated Subcutaneous Immunoglobulin 10% Safety Among Pediatric Patients With Primary Immunodeficiency Diseases	48
Chronic norovirus infection in immunodeficiency: A UK national case series	48
Allergic Rash Mimickers	48
Indoor and Outdoor Fungal Allergens and Impacts on Respiratory Allergic Disease	48
Lung Effects of Household Air Pollution	48
Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis	48
Carboplatin risk stratification after a hypersensitivity reaction: Progress in our understanding of skin testing	48
Understanding Health Equity in Patient-Reported Outcomes	48
Trends of Peanut-Induced Anaphylaxis Rates Before and After the 2017 Early Peanut Introduction Guidelines in Montreal, Canada	47
FEF25-75% Is a More Sensitive Measure Reflecting Airway Dysfunction in Patients with Asthma: A Comparison Study Using FEF25-75% and FEV1%	47
Another Therapy for Chronic Rhinosinusitis With Nasal Polyps	44
Evolving Food Allergy Clinical Trials to Become More Patient-Centered	44
Risk Factors of Hypersensitivity Reactions to Carboplatin: A Systematic Review and Meta-Analysis	43
The Role of Patient Satisfaction Scores in Clinical Care and Physician Wellness	43
Effects of Sex and Gender in Immediate β-Lactam Antibiotic Allergy: A Systematic Review and Meta-Analysis	43
Prevention of IgE-Mediated Food Allergy: Emerging Strategies Through Maternal and Neonatal Interventions	42
Hypereosinophilia following aspirin desensitization for aspirin-exacerbated respiratory disease	41
Pharmaceutical industry-sponsored meals and prescriptions of biologics for asthma	41
Sticking With It: The Continued Benefits of 2 Years of Peanut Epicutaneous Immunotherapy in Young Children	41
Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines	41
Comparative diagnostic performance of mx4-IgE versus species-specific IgE for identifying allergic bronchopulmonary aspergillosis	40
Identification of motivators and barriers impacting successful food introduction or reintroduction after negative oral food challenges	40
Skin Antiseptics for Atopic Dermatitis: Dissecting Facts From Fiction	40
Usability of Graphical User Interfaces With Semiautomatic Delabeling Feature to Improve Drug Allergy Documentation	40
Respiratory Infections in Patients with Primary Immunodeficiency	39
Assessing Pediatric Cephalosporin Allergic Reactions Through Direct Graded Oral Challenges	39
Artificial Intelligence and Machine Learning for Inborn Errors of Immunity: Current State and Future Promise	39
Hormonal Contraceptives Are Associated With an Increase in Incidence of Asthma in Women	38
European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives	38
Combination of Allergen-Specific Immunotherapy With Biologics in Severe Asthma: Counterintuitive or Rational?	38
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases	38
Epinephrine Nasal Spray Improves Allergic Symptoms in Patients Undergoing Oral Food Challenge, Phase 3 Trial	38
Is Once Versus Twice Daily Dosing Better for Adherence in Asthma and Chronic Obstructive Pulmonary Disease?	38

Application of passive monitoring of nighttime respiratory symptoms in chronic asthma management	38
Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis	37
Asthma Management in Children	37
Assessment of Real-World Escalation to Biologics in US Patients With Asthma	37
Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders	36
Reducing Health Disparities in Asthma: How Can Progress Be Made	36
Disparities in Genetic Testing for Inborn Errors of Immunity	36
A Media Advocacy Toolkit for the Allergist-Immunologist	36
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America	36
Smoking in severe asthma: Unraveling the overlap with COPD	36
Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases	36
Telemedicine utilization and incorporation of asynchronous testing in a pediatric allergy clinic during the COVID-19 pandemic	35
Clinical and diagnostic features of 33 patients with aquagenic urticaria	35
Practice Notes from the AAAI	35
Artificial Intelligence Chatbots in Allergy and Immunology Practice: Where Have We Been and Where Are We Going?	35
Preparing the Allergist/Immunologist for the Next Pandemic	34
Table of Contents	34
The Heterogeneity of Stock Epinephrine Legislation in the United States	33
Sesame-allergic patients can tolerate intact sesame seeds food challenge	33
Domiciliary assessment of the type 2 inflammatory FeNO type	33
Continuing Medical Education Calendar	33
CME exam: The Microbiome as a Gateway to Prevention of Allergic Disease Development	33
More Work to Do: Differential Responses to Asthma Therapies in Black Patients, Although Not Associated with Percentage of African Ancestry	33
The Th17/IL-17 Axis and Host Defense Against Fungal Infections	33
Prevention of Drug Hypersensitivity Reactions: Prescreening and Premedication	33
Continuing Medical Education Calendar	33
September 2023 Practice Notes	33
Barriers and Enablers of Dietary Reintroduction Following Negative Oral Food Challenge: A Scoping Review	32
Hazelnut Oral Immunotherapy Desensitizes Hazelnut But Not Other Tree Nut Allergies (Nut CRACKER Study)	32
Teleallergy: Where Have We Been and Where Are We Going?	32
Accelerating Food Allergy Research: Need for a Data Commons	31
Hypersensitivity to galcanezumab with tolerance to erenumab and fremanezumab	31
Screening Newborns for Low T Cell Receptor Excision Circles (TRECs) Fails to Detect Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome	31
Preimplantation genetic testing for hereditary angioedema as a potential dominant cost-effective intervention	31
Severity Trend of Recurrence in Pediatric Food Protein-Induced Enterocolitis Syndrome	31
Patient Perceptions of Penicillin Allergy Testing in a Public Health System	31
Table of Contents	31
Telehealth and Allergy Services in Rural and Regional Locations That Lack Specialty Services	30
The Challenges of Managing Multiple Food Allergies and Consequent Food Aversions	30
Angioedema due to Acquired C1-Inhibitor Deficiency Associated With Monoclonal Gammopathies of Undetermined Significance Characteristics of a French National Cohort	30
Multiple chemical sensitivity/idiopathic environmental intolerance: A disability-rights, patient-led perspective	30
Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19	30
Acculturation and asthma in Asian American adults	30
Does atopic dermatitis confer a clinically meaningful risk of cardiovascular disease?	30
Potential Efficacy of High-Dose Inhaled Salbutamol for the Treatment of Abdominal Pain During Oral Food Challenge	30
December 2023 Practice Notes	30
Remission of indolent systemic mastocytosis in the absence of targeted therapy	29
Comorbid Scenarios in Contact Dermatitis: Atopic Dermatitis, Irritant Dermatitis, and Extremes of Age	29
Erratum	29
Editorial Board	29
Outcomes among racial and ethnic minority groups with X-linked agammaglobulinemia from the USIDNET registry	29
Correction	29
Omalizumab treatment reduces asthma exacerbations regardless of airway bronchodilator reversibility	29
Take a Leap of Faith: Implement Routine Genetic Testing in Your Office	29
Correction	29
Frequent Allergic Sensitization to Farmed Edible Insects in Exposed Employees	28
Infrared-induced hives	28
Immediate adverse reactions to horse antithymocyte globulin: A 10-year single-center experience	28
Systemic Therapies for Atopic Dermatitis	28
The Use of Flexible Rhinolaryngoscopy for Allergy-Immunology Practice	28
Asian American Patients With Allergic Diseases: Considerations for Research and Clinical Care	28
Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency	28
Burden of Allergic Disease in Racial and Ethnic Structurally Oppressed Communities Within Canada and the United States: A Scoping Review	28
The added value of reporting likelihood ratios to laboratory test results in allergy and clinical immunology	28
Cost Control Versus Optimal Patient Care in Hereditary Angioedema	28
Omalizumab in Chronic Spontaneous Urticaria (CSU): Real-Life Experience in Dose/Interval Adjustments and Treatment Discontinuation	27
Upadacitinib-induced remission of allergic asthma: A case report	27
Use of Antibiotics in Infancy and Asthma in Childhood: Confounded or Causal Relationship? A Critical Review of the Literature	27
Sensitization is persistent in most patients with anaphylaxis to a cephalosporin at 10 years	27
Improving Detection of Alpha-1 Antitrypsin Deficiency: Role of the Allergist	27
The Environmental Microbiome, Allergic Disease, and Asthma	27
Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era	27
Clinical Characteristics of Irritant-Induced Occupational Asthma	27
Risk Factors and Age-Related Patterns of Asthma-Like Symptoms in Early Childhood	27
Clinical Assessment of Chronic Rhinosinusitis	26
Social Determinants and Quality of Life in Food Allergy Management and Treatment	26
Safety of direct oral challenge to amoxicillin in pregnant patients at a Canadian tertiary hospital	26
Food Insecurity in the Food Allergic Population: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee	26
Effectiveness of Carboplatin-Prescreening Intradermal Skin Tests to Reduce Unanticipated Immediate Hypersensitivity Reactions: A Comparative Study	26
Patient Global Impression of Severity Scale in Chronic Cough: Validation and Formulation of Symptom Severity Categories	26

Walnut Threshold Dose Distribution and Safe Dose in Allergic Patients (Nut CRACKER Study)	26
Blue Wheals and Blue Angioedema Induced by Blue Dyes: A Systematic Review	26
Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma	26
Hypertension risk in patients having hereditary angioedema with plasminogen gene mutation K330E	25
Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts	25
Factors Associated With Asthma Biologic Prescribing and Primary Adherence Among Adults in a Large Health System	25
Perceived high risk of COVID-19 vaccination: The revealing power of placebo	25
Anti-IL-5 Treatment Reduces Infection-Related Adverse Events: A Meta-Analysis of Phase 3 Clinical Trials	25
Gender and geographically based disparities among editors and editorial board members in highly cited allergy journals	25
Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey	25
Original Article Highlights From This Issue	25
Systemic Inflammation in Asthma: What Are the Risks and Impacts Outside the Airway?	25
Organizing pneumonia in patients on dupilumab therapy for nasal polyposis: A report of three cases	25
Clinical and Molecular Characteristics of X-Linked Agammaglobulinemia Patients 55 Years or Older	25
The Prevalence of IgE-Mediated Food Allergy and Other Allergic Diseases in the First 10 Years: The Population-Based, Longitudinal HealthNuts Study	25
Exercising with Asthma: A Slow Burn or a Quick HIIT?	25
Challenges and Opportunities in Asthma Prevention and Treatment	24
Drug Allergy Management on the Move	24
Allergic bronchopulmonary aspergillosis in identical twins: Effectiveness of dupilumab	24
Real-world utilization of Arachis hypogaea for peanut allergy: Patient and provider perspective	24
Contact Dermatitis of a Surgical Wound	24
Recent Advances in the Treatment of Eosinophilic Esophagitis	24
About the Cover: A New “Image” for In Practice	24
Relationships Between Chronic Cough and Asthma Control and Quality of Life in Patients With Severe Asthma: A 6-Month Longitudinal Analysis	24
Biologics and Personalized Medicine in Severe Asthma: One Step at a Time	24
Beyond Avoidance: Advanced Therapies for Contact Dermatitis	24
Asthma and Three Colinear Comorbidities: Obesity, OSA, and GERD	24
Should We Pretreat Before We Go Nuts? Antihistamines Modestly Reduce the Side Effects of Peanut Oral Immunotherapy	24
Clinical Remission in Patients With Biologic-Naïve Asthma: A Multicenter Study in Japan	24
Eosinophilic Esophagitis Patients Are Not at Increased Risk of Severe COVID-19: A Report From a Global Registry	24
Altered Symptom Perception in Children With Asthma Is Associated With Poor Childhood Opportunity and Adverse Outcomes	24
Oral immunotherapy in US allergy practice	24
Novel Connections of Common Childhood Illnesses Based on More Than 5 Million Diary Registrations From Birth Until Age 3 Years	24
Update on Influenza Vaccines: Needs and Progress	24
Trust but Verify	24
A Community-Based Participatory Research Approach to Understanding Childhood Asthma in the Navajo Nation	24
Outpatient epinephrine administration reduces ICU admission rates in anaphylactic reactions: A propensity score–matched cohort	24
The Art of Dosing for Subcutaneous Immunotherapy in North America	23
Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria	23
Positive Basophil Tests Are Linked to High Disease Activity and Other Features of Autoimmune Chronic Spontaneous Urticaria: A Systematic Review	23
Subcutaneous Emphysema Presenting as Bilateral Periorbital Angioedema	23
Inborn Errors of Immunity: A Role for Functional Testing and Flow Cytometry in Aiding Clinical Diagnosis	23
Comorbid Inducible Urticaria Is Linked to Non-Autoimmune Chronic Spontaneous Urticaria: CURE Insights	23
Elimination Diet or Swallowed Topical Steroid Treatment of Pediatric Eosinophilic Esophagitis: Five-Year Outcomes	23
Folliculocentric Mycosis Fungoides Masquerading as Angioedema and Allergic Contact Dermatitis	23
Real-World Effectiveness of Biologic Therapy in Allergic Bronchopulmonary Aspergillosis	23
Environmental Injustice Is Associated With Poorer Asthma Outcomes in School-Age Children With Asthma in Metropolitan Atlanta, Georgia	23
CME exam: Methods for Cross-Cultural Communication in Clinic Encounters	22
Patients with eosinophilic gastrointestinal disorders have lower in-hospital mortality rates related to COVID-19	22
Fatigue in Severe Uncontrolled Asthma	22
Corrections	22
Exfoliative Dermatitis During Antituberculosis Treatment	22
Original Article Highlights From This Issue	22
Current Management of Allergic Rhinitis	22
A single-center experience of treating 19 patients with chronic cold urticaria	22
Allergic Mucin in Allergic Fungal Rhinosinusitis	22
Information for Readers	22
COVID-19 and Pregnancy: Interrelationships With Asthma and Allergy	22
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical presentation and outcomes in people of color	22
Why Was There Ever a Warning Not to Use Cephalosporins in the Setting of a Penicillin “Allergy”?	22
Pulmonary Infiltrates With Hypereosinophilia	22
Polycystic ovary syndrome and the risk of asthma in reproductive-age women: Insights from 2 real-world large cohorts	21
Reply to “The use of basophil activation tests (BATs) in the diagnosis of penicillin allergy”	21
Genetic Counseling in Pediatric Inborn Errors of Immunity: Perspective Piece on Current Practice and Considerations	21
Pretreatment with ibrutinib facilitates rapid drug desensitization in a difficult case of brentuximab vedotin–induced anaphylaxis	21
Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy	21
The Art of Immunotherapy	21
Patient-Centered Immunotherapy: Empowering Patients With Dosing Schedule Education and Self-Tracking Modality	21
Early-Life Allergen Exposure and Its Influence on Risk of Atopic Disease	21
Smoke and the Lungs	21
Racial and Ethnic Disparities in the Research and Care of Hereditary Angioedema Patients in the United States	21
Comparison of Standard, Cluster, and Rush Allergy Immunotherapy Buildup Protocols	21
Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease	21
Housing Mobility Intervention and the Impact on Pediatric Asthma Morbidity: A Novel Asthma-Directed Therapy	21
Information for Readers	21
More Than Moderate-Dose Inhaled Corticosteroid Therapy for Difficult-to-Treat Asthma: One Step Too Many?	20
Analyzing Racial Disparities in Pediatric Atopic Comorbidity Emergency Department Visitation Using Electronic Health Records	20
Association between social needs and asthma control among children evaluated at a single-center high-risk asthma clinic	20
Drug Reaction With Eosinophilia and Systemic Symptoms: A Systematic Review	20
Association Between Blood Eosinophils and Neutrophils With Clinical Features in Adult-Onset Asthma	20
The Magnification of Health Disparities During the COVID-19 Pandemic	20
Delayed Skin Testing for Systemic Medications: Helpful or Not?	20
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus	20
Diagnosis and Treatment Options for T2-Low Asthma	20
Novel Questionnaires for Assessing Signs and Symptoms of Eosinophilic Esophagitis in Children	20
Budesonide/Formoterol or Budesonide/Albuterol as Anti-Inflammatory Reliever Therapy for Asthma	20
Increased Risk of Atrial Fibrillation in Patients with Atopic Triad: A Nationwide Population-Based Study	20
Results From a National Survey of Asthma Provider Beliefs and Practices Regarding Exercise and Asthma: A Work Group Report of the AAAAI Committee on Sports, Exercise, and Fitness	19
Elevating Health Disparities Education Among Trainees and Physicians	19
Hospital-Initiated Care Bundle, Posthospitalization Care, and Outcomes in Adults with Asthma Exacerbation	19
Inhaled Corticosteroid–Induced Adrenal Suppression in Patients With Asthma Detected by Metabolomic Profiling	19
Information for Readers	19
Impairment of EQ-5D-5L Domains According to Allergic Rhinitis and Asthma Control: A MASK-air Real-World Study	19
Genetic Variants Leading to Urticaria and Angioedema and Associated Biomarkers	19
Editorial Board	19